Biomarkers
Volume 28, 2023 - Issue 1
Original Articles
Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers
David AzzopardiBritish American Tobacco (Investments) Ltd., R&D Centre, Southampton, UKCorrespondence[email protected]
https://orcid.org/0000-0003-3093-3840
https://orcid.org/0000-0003-3093-3840, Linsey E. HaswellBritish American Tobacco (Investments) Ltd., R&D Centre, Southampton, UKhttps://orcid.org/0000-0002-5663-8834
https://orcid.org/0000-0002-5663-8834, Justin FrosinaBritish American Tobacco (Investments) Ltd., R&D Centre, Southampton, UKhttps://orcid.org/0000-0002-5930-6480
https://orcid.org/0000-0002-5930-6480, Michael McEwanBritish American Tobacco (Investments) Ltd., R&D Centre, Southampton, UKhttps://orcid.org/0000-0001-5561-4438
https://orcid.org/0000-0001-5561-4438, Nathan GaleBritish American Tobacco (Investments) Ltd., R&D Centre, Southampton, UKhttps://orcid.org/0000-0002-7215-1225
https://orcid.org/0000-0002-7215-1225, Jesse ThissenBritish American Tobacco (Investments) Ltd., R&D Centre, Southampton, UKhttps://orcid.org/0000-0002-1122-3985
https://orcid.org/0000-0002-1122-3985, Filimon MeichanetzidisBritish American Tobacco (Investments) Ltd., R&D Centre, Southampton, UKhttps://orcid.org/0000-0001-6556-8383
https://orcid.org/0000-0001-6556-8383 & George HardieBritish American Tobacco (Investments) Ltd., R&D Centre, Southampton, UKhttps://orcid.org/0000-0003-1079-9381
https://orcid.org/0000-0003-1079-9381 show all